Sfoglia per Rivista HAEMATOLOGICA
SAFETY AND EFFICACY OF RUXOLITINIB IN CLINICAL PRACTICE FOR PRIMARY AND SECONDARY MYELOFIBROSIS
2016 Breccia, M; Andriani, A; Montanaro, M; Abruzzese, E; Buccisano, F; Cedrone, M; Centra, A; Villiva, N; Celesti, F; Trawinska, Mm; Di Veroli, A; Anaclerico, B; Colafigli, G; Spadea, A; Petriccione, L; Cimino, G; Latagliata, R; Alimena, G
Safety and toxicity of intrathecal liposomal cytarabine for treating central nervous system (CNS) relapse in pediatric acute leukemia: a multicenter retrospective study
2011 Parasole, R; Petruzziello, F; Messina, C; Pession, A; Barisone, E; Locatelli, F; Concetta, C; Testi, Anna Maria; Varotto, S; Morello, W; Calvillo, M; Berger, M; Menna, G; Poggi, V.
Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the Phase 3b GREEN study
2018 Leblond, V; Aktan, M; Ferra Coll CM, ; Dartigeas, C; Kisro, J; Montillo, M; Raposo, J; Merot, Jl; Robson, S; Gresko, E; Bosch, F; Stilgenbauer, S; Foà, R
Salvage use of allogeneic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the EBMT Chronic Malignancies Working Party
2017 Sobh, M; Michallet, M; Dubois, V; Iacobelli, Simona; Koster, L; Van Biezen, A; Fegueux, N; Tabrizi, R; Finke, J; El Cheikh, J; Schipperus, M; Meijer, E; von dem Borne, P; Petersen, E; Russell, N; Tholouli, E; Passweg, J; Garban, F; Maertens, J; Chevalier, P; Maillard, N; Volin, L; Francois, S; Lioure, B; Beguin, Y; Gluckman, E; Ruggeri, A; Garderet, L; Kröger, N.
SECOND MALIGNANCIES IN 559 CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH IMATINIB – A SURVEY BY THE GIMEMA CML WP
2011 Gugliotta, G; 1 Castagnetti, F; 1 Palandri, F; Breccia, M; Cavazzini, F; Di Lorenzo, R; Levato, L; Girasoli, M; Leone, G; Abruzzese, E; Tiribelli, M; Meneghini, V; Galieni, P; Binotto, G; Nicolini, G; Alimena, G; Martinelli, G; Pane, F; Saglio, G; Baccarani, M; Rosti, G
SECOND MALIGNANCIES IN 559 PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB FRONTLINE: DATA FROM THE GIMEMA CML WORKING PARTY
2010 Gugliotta, G; Castagnetti, F; Palandri, F; Breccia, M; Radaelli, F; Capucci, A; Cavazzini, F; Ferrero, D; Stagno, F; Gherlinzoni, F; Di Lorenzo, R; Leoni, P; Rege Cambrin, G; Ferrara, F; Alimena, G; Martinelli, G; Pane, F; Saglio, G; Baccarani, M; Rosti, G
Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials
2017 Eichenauer, Dennis A.; Becker, Ingrid; Monsef, Ina; Chadwick, Nicholas; De Sanctis, Vitaliana; Federico, Massimo; Fortpied, Catherine; Gianni, Alessandro M.; Henry-amar, Michel; Hoskin, Peter; Johnson, Peter; Luminari, Stefano; Bellei, Monica; Pulsoni, Alessandro; Sydes, Matthew R.; Valagussa, Pinuccia; Viviani, Simonetta; Engert, Andreas; Franklin, Jeremy
Semiautomated autologous bone marrow processing for transplantation.
1991 Pierelli, Luca; G., Menichella; A., Paoloni; R., Serafini; M., Vittori; M. L., Foddai; F., Meoni; P. L., Rossi; G., Leone; G., Mango
Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: A phase II study (AML-15) of the EORTC and GIMEMA leukemia groups
2004 S., Amadori; S., Suciu; R., Willemze; Mandelli, Franco; D., Selleslag; R., Stauder; A., Ho; C., Denzlinger; G., Leone; P., Fabris; P., Muus; Vignetti, Marco; A., Hagemeijer; F., Beeldens; O., Anak; T., De Witte
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: Final results of the GIMEMA LAL 0904 study
2016 Chiaretti, Sabina; Vitale, Antonella; Vignetti, Marco; Piciocchi, Alfonso; Fazi, Paola; Elia, Loredana; Falini, Brunangelo; Ronco, Francesca; Ferrara, Felicetto; De Fabritiis, Paolo; Luppi, Mario; La Nasa, Giorgio; Tedeschi, Alessandra; Califano, Catello; Fanin, Renato; Dore, Fausto; Mandelli, Franco; Meloni, Giovanna; Foa, Roberto
Sequential molecular monitoring of chimerism status in two patients transplanted with double unrelated donor umbilical cord blood
2007 Elia, L; Iori, Ap; Falciani, V.; Grammatico, S.; Malandruccolo, L.; Milano, F.; Torelli, Fg; Grammatico, P.; Antigoni, I.; Lucarelli, B.; Loglisci, G.; Valle, V; Iannotta, E.; Arleo, E.; Cimino, Giuseppe; Foa, Roberto
SEQUENTIAL TREATMENT WITH LOW DOSES OF RETINOIC ACID (LOATRA) VALPROIC ACID(VPA) FOLLOWED BY LOW DOSES ARAC(LODAC) IN ELDERLY ACUTE MYELOID LEUKAEMIA(AML) PRELIMINARY CLINICAL AND BIOLOGICAL RESULTS
2008 S., Fenu; C., Nobile; Nervi, Clara; A., Chierichini; P., Anticoli Borza; B., Anaclerico; V., Bongarzoni; R., Bruno; S., Cortese; P., Iacovino; F., Pauselli; C., Tozzi; Cimino, Giuseppe; L., Annino
Serial study of C-reactive protein for the diagnosis of bacterial and fungal infections in neutropenic patients with hematologic malignancies.
1988 Venditti, Mario; Brandimarte, C; Trobiani, P; Fenu, S; Martino, P; Serra, P; Mandelli, F.
Seronegative antiphospholipid syndrome: Refining the value of “non-criteria” antibodies for diagnosis and clinical management
2020 Pignatelli, P.; Ettorre, E.; Menichelli, D.; Pani, A.; Violi, F.; Pastori, D.
Serum erythropoietin level and marrow erythroid infiltration predict response to recombinant human erythropoietin in myelodysplastic syndromes.
1993 Depaoli, L.; Levis, A.; Isabella, N.; Ficara, F.; Priotto, C.; Lista, P.; Foa, Roberto; Resegotti, L.
Serum phospholipids are the main environmental determinants of activated factor VII levels in the most common FVII genotype.
1999 Mariani, Guglielmo; Bernardi, F.; Bertina, R.; VICENTE GARCIA, V.; Prydz, H.; Samama, M.; Sandset, P. M.; DI NUCCI, Gian Domenico; Testa, Maria Grazia; Bendz, B.; Chiarotti, F.; Ciarla, Maria Vera; Strom, Roberto
SEVEN YEAR-EXPERIENCE OF BCR-ABL MUTATION ANALYSIS IN PHILADELPHIA-CHROMOSOME POSITIVE (PH+) PATIENTS ON IMATINIB (IM) OR 2ND-GENERATION TYROSINE KINASE INHIBITORS (TKIS): BY THE GIMEMA CML WORKING PARTY
2011 Soverini, S; Gnani, A; De Benedittis, C; Castagnetti, F; Gugliotta, G; Breccia, M; Pregno, P; Abruzzese, E; Sorà, F; Baratè, C; Gangemi, D; Capucci, A; Girasoli, M; Orlandi, E; Specchia, G; Russo, D; Giannini, B; Poletti, G; Iacobucci, I; Bochicchio, T; Pane, F; Saglio, G; Rosti, G; Baccarani, M; Martinelli, G
SEX CORRELATED WITH DIFFERENCES IN LONG-TERM OUTCOME IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH IMATINIB
2015 Breccia, M; Colafigli, G; Molica, M; De Angelis, F; Quattrocchi, L; Latagliata, R; Mancini, M; Diverio, D; Alimena, G
Signal transduction pathway involved in platelet activation in immune thrombotic thrombocytopenia after COVID-19 vaccination
2022 Misasi, R.; Capozzi, A.; Riitano, G.; Recalchi, S.; Manganelli, V.; Mattei, V.; Longo, A.; de Michele, M.; Garofalo, T.; Pulcinelli, F. M.; Sorice, M.
Simultaneous inhibition of the Raf/MEK/ERK and Bcl-2 pathways results in strikingly synergistic induction of apoptosis in multiple myeloma cells.
2008 Ricciardi, Maria Rosaria; Libotte, F; Calabrese, E; Bergamo, P; Santinelli, S; Decandia, S; Federico, Vincenzo; Foà, R; Tafuri, Agostino; Milella, M; Petrucci, M. T.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| SAFETY AND EFFICACY OF RUXOLITINIB IN CLINICAL PRACTICE FOR PRIMARY AND SECONDARY MYELOFIBROSIS | 2016 | Breccia, M; Andriani, A; Montanaro, M; Abruzzese, E; Buccisano, F; Cedrone, M; Centra, A; Villiva, N; Celesti, F; Trawinska, Mm; Di Veroli, A; Anaclerico, B; Colafigli, G; Spadea, A; Petriccione, L; Cimino, G; Latagliata, R; Alimena, G | |
| Safety and toxicity of intrathecal liposomal cytarabine for treating central nervous system (CNS) relapse in pediatric acute leukemia: a multicenter retrospective study | 2011 | Parasole, R; Petruzziello, F; Messina, C; Pession, A; Barisone, E; Locatelli, F; Concetta, C; Testi, Anna Maria; Varotto, S; Morello, W; Calvillo, M; Berger, M; Menna, G; Poggi, V. | |
| Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the Phase 3b GREEN study | 2018 | Leblond, V; Aktan, M; Ferra Coll CM, ; Dartigeas, C; Kisro, J; Montillo, M; Raposo, J; Merot, Jl; Robson, S; Gresko, E; Bosch, F; Stilgenbauer, S; Foà, R | |
| Salvage use of allogeneic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the EBMT Chronic Malignancies Working Party | 2017 | Sobh, M; Michallet, M; Dubois, V; Iacobelli, Simona; Koster, L; Van Biezen, A; Fegueux, N; Tabrizi, R; Finke, J; El Cheikh, J; Schipperus, M; Meijer, E; von dem Borne, P; Petersen, E; Russell, N; Tholouli, E; Passweg, J; Garban, F; Maertens, J; Chevalier, P; Maillard, N; Volin, L; Francois, S; Lioure, B; Beguin, Y; Gluckman, E; Ruggeri, A; Garderet, L; Kröger, N. | |
| SECOND MALIGNANCIES IN 559 CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH IMATINIB – A SURVEY BY THE GIMEMA CML WP | 2011 | Gugliotta, G; 1 Castagnetti, F; 1 Palandri, F; Breccia, M; Cavazzini, F; Di Lorenzo, R; Levato, L; Girasoli, M; Leone, G; Abruzzese, E; Tiribelli, M; Meneghini, V; Galieni, P; Binotto, G; Nicolini, G; Alimena, G; Martinelli, G; Pane, F; Saglio, G; Baccarani, M; Rosti, G | |
| SECOND MALIGNANCIES IN 559 PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB FRONTLINE: DATA FROM THE GIMEMA CML WORKING PARTY | 2010 | Gugliotta, G; Castagnetti, F; Palandri, F; Breccia, M; Radaelli, F; Capucci, A; Cavazzini, F; Ferrero, D; Stagno, F; Gherlinzoni, F; Di Lorenzo, R; Leoni, P; Rege Cambrin, G; Ferrara, F; Alimena, G; Martinelli, G; Pane, F; Saglio, G; Baccarani, M; Rosti, G | |
| Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials | 2017 | Eichenauer, Dennis A.; Becker, Ingrid; Monsef, Ina; Chadwick, Nicholas; De Sanctis, Vitaliana; Federico, Massimo; Fortpied, Catherine; Gianni, Alessandro M.; Henry-amar, Michel; Hoskin, Peter; Johnson, Peter; Luminari, Stefano; Bellei, Monica; Pulsoni, Alessandro; Sydes, Matthew R.; Valagussa, Pinuccia; Viviani, Simonetta; Engert, Andreas; Franklin, Jeremy | |
| Semiautomated autologous bone marrow processing for transplantation. | 1991 | Pierelli, Luca; G., Menichella; A., Paoloni; R., Serafini; M., Vittori; M. L., Foddai; F., Meoni; P. L., Rossi; G., Leone; G., Mango | |
| Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: A phase II study (AML-15) of the EORTC and GIMEMA leukemia groups | 2004 | S., Amadori; S., Suciu; R., Willemze; Mandelli, Franco; D., Selleslag; R., Stauder; A., Ho; C., Denzlinger; G., Leone; P., Fabris; P., Muus; Vignetti, Marco; A., Hagemeijer; F., Beeldens; O., Anak; T., De Witte | |
| A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: Final results of the GIMEMA LAL 0904 study | 2016 | Chiaretti, Sabina; Vitale, Antonella; Vignetti, Marco; Piciocchi, Alfonso; Fazi, Paola; Elia, Loredana; Falini, Brunangelo; Ronco, Francesca; Ferrara, Felicetto; De Fabritiis, Paolo; Luppi, Mario; La Nasa, Giorgio; Tedeschi, Alessandra; Califano, Catello; Fanin, Renato; Dore, Fausto; Mandelli, Franco; Meloni, Giovanna; Foa, Roberto | |
| Sequential molecular monitoring of chimerism status in two patients transplanted with double unrelated donor umbilical cord blood | 2007 | Elia, L; Iori, Ap; Falciani, V.; Grammatico, S.; Malandruccolo, L.; Milano, F.; Torelli, Fg; Grammatico, P.; Antigoni, I.; Lucarelli, B.; Loglisci, G.; Valle, V; Iannotta, E.; Arleo, E.; Cimino, Giuseppe; Foa, Roberto | |
| SEQUENTIAL TREATMENT WITH LOW DOSES OF RETINOIC ACID (LOATRA) VALPROIC ACID(VPA) FOLLOWED BY LOW DOSES ARAC(LODAC) IN ELDERLY ACUTE MYELOID LEUKAEMIA(AML) PRELIMINARY CLINICAL AND BIOLOGICAL RESULTS | 2008 | S., Fenu; C., Nobile; Nervi, Clara; A., Chierichini; P., Anticoli Borza; B., Anaclerico; V., Bongarzoni; R., Bruno; S., Cortese; P., Iacovino; F., Pauselli; C., Tozzi; Cimino, Giuseppe; L., Annino | |
| Serial study of C-reactive protein for the diagnosis of bacterial and fungal infections in neutropenic patients with hematologic malignancies. | 1988 | Venditti, Mario; Brandimarte, C; Trobiani, P; Fenu, S; Martino, P; Serra, P; Mandelli, F. | |
| Seronegative antiphospholipid syndrome: Refining the value of “non-criteria” antibodies for diagnosis and clinical management | 2020 | Pignatelli, P.; Ettorre, E.; Menichelli, D.; Pani, A.; Violi, F.; Pastori, D. | |
| Serum erythropoietin level and marrow erythroid infiltration predict response to recombinant human erythropoietin in myelodysplastic syndromes. | 1993 | Depaoli, L.; Levis, A.; Isabella, N.; Ficara, F.; Priotto, C.; Lista, P.; Foa, Roberto; Resegotti, L. | |
| Serum phospholipids are the main environmental determinants of activated factor VII levels in the most common FVII genotype. | 1999 | Mariani, Guglielmo; Bernardi, F.; Bertina, R.; VICENTE GARCIA, V.; Prydz, H.; Samama, M.; Sandset, P. M.; DI NUCCI, Gian Domenico; Testa, Maria Grazia; Bendz, B.; Chiarotti, F.; Ciarla, Maria Vera; Strom, Roberto | |
| SEVEN YEAR-EXPERIENCE OF BCR-ABL MUTATION ANALYSIS IN PHILADELPHIA-CHROMOSOME POSITIVE (PH+) PATIENTS ON IMATINIB (IM) OR 2ND-GENERATION TYROSINE KINASE INHIBITORS (TKIS): BY THE GIMEMA CML WORKING PARTY | 2011 | Soverini, S; Gnani, A; De Benedittis, C; Castagnetti, F; Gugliotta, G; Breccia, M; Pregno, P; Abruzzese, E; Sorà, F; Baratè, C; Gangemi, D; Capucci, A; Girasoli, M; Orlandi, E; Specchia, G; Russo, D; Giannini, B; Poletti, G; Iacobucci, I; Bochicchio, T; Pane, F; Saglio, G; Rosti, G; Baccarani, M; Martinelli, G | |
| SEX CORRELATED WITH DIFFERENCES IN LONG-TERM OUTCOME IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH IMATINIB | 2015 | Breccia, M; Colafigli, G; Molica, M; De Angelis, F; Quattrocchi, L; Latagliata, R; Mancini, M; Diverio, D; Alimena, G | |
| Signal transduction pathway involved in platelet activation in immune thrombotic thrombocytopenia after COVID-19 vaccination | 2022 | Misasi, R.; Capozzi, A.; Riitano, G.; Recalchi, S.; Manganelli, V.; Mattei, V.; Longo, A.; de Michele, M.; Garofalo, T.; Pulcinelli, F. M.; Sorice, M. | |
| Simultaneous inhibition of the Raf/MEK/ERK and Bcl-2 pathways results in strikingly synergistic induction of apoptosis in multiple myeloma cells. | 2008 | Ricciardi, Maria Rosaria; Libotte, F; Calabrese, E; Bergamo, P; Santinelli, S; Decandia, S; Federico, Vincenzo; Foà, R; Tafuri, Agostino; Milella, M; Petrucci, M. T. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile